Bal Pharma Ltd. · CashKonnect

About

Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; herbal liver protective and antioxidant; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Key Metrics

as of Sep 2026

Market Cap140 Cr

P/E19.40

Div Yield1.37 %

Book Value₹51.60

52w High₹99.00

52w Low₹59.70

Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	88.62	84.08	87.69	74.02	65.87	81.88	73.15	73.69	74.36	94.63	81.66	92.54	70.39
Expenses	80.67	73.50	78.15	68.29	59.81	74.24	65.40	66.00	67.89	85.03	73.87	84.84	63.95
Operating Profit	7.95	10.58	9.54	5.73	6.06	7.64	7.75	7.69	6.47	9.60	7.79	7.70	6.44
OPM %	8.97	12.58	10.88	7.74	9.20	9.33	10.59	10.44	8.70	10.14	9.54	8.32	9.15
Other Income	0.44	-0.24	0.33	1.12	0.72	1.08	0.51	-0.20	0.82	2.45	0.10	0.14	0.16
Depreciation	2.78	3.06	3.23	2.27	2.52	2.18	2.69	2.48	2.43	2.16	2.96	2.42	2.53
Interest	4.47	4.06	4.85	3.86	4.05	3.95	5.01	3.65	4.24	4.14	3.66	3.82	3.64
Profit before tax	1.14	3.22	1.79	0.72	0.21	2.59	0.56	1.36	0.62	5.75	1.27	1.60	0.43
Tax %	0.00	-12.11	0.00	0.00	0.00	-108.88	7.14	23.53	58.06	3.65	33.07	39.38	79.07
Net Profit	1.13	3.60	1.79	0.72	0.21	5.41	0.52	1.04	0.26	5.53	0.85	0.97	0.09
EPS in Rs	0.70	2.25	1.12	0.45	0.13	3.41	0.30	0.65	0.16	3.46	0.56	0.61	0.05

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	312.00	303.00	339.00	304.00	281.00	251.00	171.00	225.00	211.00	229.00	198.00	187.00
Expenses	280.00	273.00	308.00	279.00	257.00	226.00	166.00	207.00	194.00	214.00	183.00	170.00
Operating Profit	32.00	30.00	31.00	25.00	24.00	25.00	5.00	18.00	17.00	15.00	15.00	17.00
OPM %	10.00	10.00	9.00	8.00	9.00	10.00	2.90	8.00	8.00	6.00	7.00	9.00
Other Income	2.00	2.00	3.00	1.00	5.00	1.00	2.00	1.00	2.00	3.00	1.00	1.00
Interest	17.00	17.00	15.00	12.00	11.00	12.00	13.00	13.00	9.00	8.00	6.00	7.00
Depreciation	11.00	10.00	10.00	9.00	9.00	10.00	8.00	6.00	7.00	6.00	7.00	7.00
Profit before tax	6.00	5.00	9.00	5.00	9.00	4.00	-14.00	0.00	3.00	3.00	3.00	5.00
Tax %	-7.00	-41.00	18.00	45.00	38.00	-15.00	-5.00	-1,175.00	87.00	114.00	90.00	25.00
Net Profit	6.00	7.00	7.00	3.00	6.00	5.00	-13.00	2.00	0.00	0.00	1.00	4.00
EPS in Rs	3.94	4.53	4.68	1.64	3.78	3.20	-8.62	2.67	1.96	1.24	1.10	2.82
Dividend Payout %	30.00	26.00	26.00	61.00	26.00	31.00	0.00	37.00	51.00	81.00	91.00	35.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	16.00	16.00	16.00	16.00	15.00	15.00	14.00	14.00	14.00	14.00	13.00	13.00
Reserves	66.00	62.00	56.00	48.00	44.00	39.00	38.00	52.00	51.00	48.00	42.00	42.00
Borrowings	160.00	150.00	140.00	131.00	104.00	110.00	118.00	124.00	110.00	93.00	89.00	49.00
Other Liabilities	134.00	108.00	108.00	116.00	98.00	76.00	68.00	71.00	86.00	78.00	67.00	59.00
Total Liabilities	376.00	336.00	320.00	311.00	261.00	240.00	238.00	261.00	260.00	233.00	211.00	164.00
Fixed Assets	94.00	87.00	80.00	76.00	67.00	69.00	71.00	70.00	71.00	60.00	56.00	52.00
CWIP	7.00	3.00	0.00	0.00	2.00	0.00	3.00	4.00	0.00	2.00	4.00	1.00
Investments	2.00	2.00	7.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	272.00	244.00	233.00	235.00	192.00	172.00	164.00	187.00	188.00	172.00	151.00	111.00
Total Assets	376.00	336.00	320.00	311.00	261.00	240.00	238.00	261.00	260.00	233.00	211.00	164.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	30.00	20.00	23.00	-2.00	27.00	22.00	23.00	8.00	1.00	6.00	-19.00	15.00
Cash from Investing Activity	-21.00	-15.00	-19.00	-22.00	-9.00	-6.00	-5.00	-8.00	-4.00	-8.00	-14.00	-5.00
Cash from Financing Activity	-10.00	-8.00	-1.00	24.00	-17.00	-17.00	-20.00	0.00	4.00	-6.00	32.00	-7.00
Net Cash Flow	0.00	-2.00	3.00	0.00	0.00	0.00	-2.00	0.00	1.00	-8.00	-1.00	2.00
Free Cash Flow	8.00	2.00	12.00	-16.00	18.00	19.00	18.00	-1.00	-3.00	-2.00	-34.00	9.00
CFO/OP %	95.00	75.00	88.00	-4.00	117.00	91.00	465.00	57.00	11.00	52.00	-125.00	93.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	110.00	111.00	107.00	113.00	98.00	98.00	106.00	105.00	111.00	99.00	105.00	88.00
Inventory Days	269.00	238.00	167.00	207.00	162.00	146.00	292.00	217.00	240.00	172.00	145.00	132.00
Days Payable	206.00	189.00	147.00	167.00	143.00	114.00	167.00	147.00	182.00	171.00	163.00	142.00
Cash Conversion Cycle	173.00	161.00	127.00	153.00	117.00	130.00	231.00	175.00	168.00	100.00	87.00	78.00
Working Capital Days	7.00	6.00	12.00	13.00	18.00	11.00	-11.00	25.00	45.00	26.00	50.00	14.00
ROCE %	10.00	10.00	12.00	10.00	12.00	10.00	0.00	7.00	8.00	8.00	7.00	11.00

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	50.87	50.87	50.87	50.87	50.87	50.87	50.87	50.87	51.24	51.24	51.24	51.61
FIIs	0.15	0.14	0.14	0.23	0.15	0.14	0.14	0.13	0.13	0.13	0.13	0.14
Public	48.99	49.01	49.01	48.91	48.99	49.01	49.00	49.01	48.63	48.64	48.64	48.25
No. of Shareholders	14,974	15,214	15,520	15,774	15,826	15,723	15,667	16,007	15,014	14,772	15,060	15,529

Corporate Actions

23 records

Action	Ex Date	Record Date	Ratio	Amount (₹)	Notes
Dividend	18 Sep 2025	18 Sep 2025	—	1.20
Dividend	17 Sep 2024	—	—	1.20
Dividend	18 Sep 2023	—	—	1.00
Dividend	13 Sep 2022	—	—	1.00
Dividend	16 Sep 2021	—	—	1.00
Other	17 Sep 2020	—	—	—	Annual General Meeting
Dividend	17 Sep 2019	—	—	1.00
Dividend	14 Sep 2018	—	—	1.00
Dividend	14 Sep 2017	—	—	1.00
Dividend	15 Sep 2016	—	—	1.00
Dividend	15 Sep 2015	—	—	1.00
Dividend	12 Sep 2014	—	—	1.00
Dividend	12 Sep 2013	—	—	0.75
Other	17 Sep 2012	—	—	—	Annual General Meeting
Other	19 Sep 2011	—	—	—	Annual General Meeting
Other	23 Sep 2010	—	—	—	Annual General Meeting
Dividend	17 Sep 2009	—	—	0.75
Other	17 Sep 2009	—	—	—	Dividend-Re.0.75 Pr Share
Dividend	09 Sep 2008	—	—	1.00
Dividend	07 Sep 2007	—	—	0.75
Dividend	07 Sep 2006	—	—	0.75
Other	07 Apr 2005	15 Apr 2005	—	—	Right Issue of Equity Shares
Dividend	03 Sep 2001	—	—	1.00